approval · primary record
DALBAVANCIN HYDROCHLORIDE
FDA · NDA · 2025-01-13
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2025-01-13 |
| Brand | DALVANCE |
| Sponsor | ABBVIE |
| Route | INTRAVENOUS |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:20.841Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:DALBAVANCIN HYDROCHLORIDE:2025-01-13
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.